Reckitt focus on health and hygiene initiatives helps winning Global Health Awards 2025 at House of Commons, London: Our ...

Takeda announces positive results from two pivotal phase 3 studies of oveporexton in narcolepsy type 1: Osaka Wednesday, July 16, 2025, 16:30 Hrs [IST] Takeda, a global company fo ...

Baxdrostat meets primary and all secondary endpoints in BaxHTN phase III trial in patients with uncontrolled or treatment resistant hypertension: Cambridge, UK Wednesday, July 16, ...

Synendos Therapeutics appoints Dr. George Garibaldi to move phase 2 clinical development of its lead drug asset SYT-510: Basel, Switzerland Wednesday, July 16, 2025, 15:45 Hrs [IS ...

Marengo Asia Hospitals opens MAINS to focus on neuro appoints Dr Praveen Gupta as chairman: Our Bureau, Bengaluru Wednesday, July 16, 2025, 15:50 Hrs [IST] Marengo Asia Hospitals ...

Imugene announces phase 1b trial evaluating azer-cel in patients with relapsed/refractory diffuse large B-cell lymphoma: Sydney Wednesday, July 16, 2025, 15:30 Hrs [IST] Imugene L ...

Nanoscope Therapeutics begins rolling submission of BLA to US FDA for gene-agnostic therapy, MCO-010 to treat retinitis pigmentosa: Dallas, Texas Wednesday, July 16, 2025, 14:30 H ...

GSK announces US FDA accepts application to review expanded use of RSV vaccine, Arexvy for adults 18-49 at increased risk: London, UK Wednesday, July 16, 2025, 14:00 Hrs [IST] GSK ...

CMRI Kolkata launches free cervical cancer vaccination clinic to safeguard girls and young women: Our Bureau, Mumbai’ Wednesday, July 16, 2025, 15:15 Hrs [IST] CK Birla Hospital ...

Boehringer Ingelheim & LEO Pharma partner to commercialize and further develop Spevigo: Ingelheim, Germany Wednesday, July 16, 2025, 15:00 Hrs [IST] Boehringer Ingelheim, a biopha ...

ManipalCigna Health Insurance lines up aggressive expansion plan: Our Bureau, Bengaluru Wednesday, July 16, 2025, 13:40 Hrs [IST] ManipalCigna Health Insurance Company has planned ...

US FDA approves Bayer’s finerenone for new indication in patients with heart failure with left ventricular ejection fraction of ≥ 40%: Berlin Wednesday, July 16, 2025, 13:00 H ...